Healthcare Realty 预计2025年EPS亏损在$(0.28)-$(0.20)之间，相比2024年亏损$(1.81)，正常化FFO为$1.56-$1.60，同比增长$1.56

财报速递

19 Feb

公司预计2025年每股收益指南范围如下：2024年实际每股收益亏损$(1.81)，2025年预计为$(0.28)至$(0.20)；NAREIT每股FFO为$0.52，预计2025年在$1.44至$1.48之间；2024年正常化每股FFO为$1.56，预计2025年在$1.56至$1.60之间。公司的2025年同店现金NOI增长预计在3.00%到3.75%之间，不包括Prospect Medical和Steward Health的影响。

以上内容来自Benzinga Earnings专栏，原文如下：

GuidanceThe Company's 2025 per share estimated guidance ranges are as follows: ACTUAL 2025 GUIDANCE 2024 LOWHIGHEarnings per share$(1.81) $(0.28)$(0.20)NAREIT FFO per

Guidance

The Company's 2025 per share estimated guidance ranges are as follows:

	ACTUAL				2025 GUIDANCE
		2024		LOW				HIGH
Earnings per share	$	(1.81	)		$	(0.28	)	$	(0.20	)
NAREIT FFO per share	$	0.52			$	1.44		$	1.48
Normalized FFO per share	$	1.56			$	1.56		$	1.60

The Company's 2025 same store cash NOI growth estimated guidance range is 3.00% to 3.75%, which excludes the impact of Prospect Medical and Steward Health.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1143584451"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1143584451\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1143584451?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-02-19 20:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1143584451","market":"us","top_or_hot":-1,"title":"Healthcare Realty 预计2025年EPS亏损在$(0.28)-$(0.20)之间，相比2024年亏损$(1.81)，正常化FFO为$1.56-$1.60，同比增长$1.56","media":"财报速递","content":"公司预计2025年每股收益指南范围如下：2024年实际每股收益亏损$(1.81)，2025年预计为$(0.28)至$(0.20)；NAREIT每股FFO为$0.52，预计2025年在$1.44至$1.48之间；2024年正常化每股FFO为$1.56，预计2025年在$1.56至$1.60之间。公司的2025年同店现金NOI增长预计在3.00%到3.75%之间，不包括Prospect Medical和Steward Health的影响。<br><br>以上内容来自Benzinga Earnings专栏，原文如下：<br><html><body><p>GuidanceThe Company's 2025 per share estimated guidance ranges are as follows: ACTUAL 2025 GUIDANCE  2024  LOWHIGHEarnings per share$(1.81) <a href=\"https://laohu8.com/S/0.28\">$(0.28)$</a>(0.20)NAREIT FFO per</p><p>Guidance</p><ul><li>The Company's 2025 per share estimated guidance ranges are as follows:</li></ul><figure><table><tbody><tr><td> </td><td colspan=\"3\">ACTUAL</td><td> </td><td colspan=\"6\">2025 GUIDANCE</td></tr><tr><td> </td><td> </td><td>2024</td><td> </td><td colspan=\"4\"> LOW</td><td colspan=\"3\">HIGH</td></tr><tr><td>Earnings per share</td><td>$</td><td>(1.81</td><td>)</td><td> </td><td>$</td><td>(0.28</td><td>)</td><td>$</td><td>(0.20</td><td>)</td></tr><tr><td>NAREIT FFO per share</td><td>$</td><td>0.52</td><td> </td><td> </td><td>$</td><td>1.44</td><td> </td><td>$</td><td>1.48</td><td> </td></tr><tr><td>Normalized FFO per share</td><td>$</td><td>1.56</td><td> </td><td> </td><td>$</td><td>1.56</td><td> </td><td>$</td><td>1.60</td><td> </td></tr></tbody></table></figure><ul><li>The Company's 2025 same store cash NOI growth estimated guidance range is 3.00% to 3.75%, which excludes the impact of Prospect Medical and Steward Health.</li></ul></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Healthcare Realty 预计2025年EPS亏损在$(0.28)-$(0.20)之间，相比2024年亏损$(1.81)，正常化FFO为$1.56-$1.60，同比增长$1.56</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHealthcare Realty 预计2025年EPS亏损在$(0.28)-$(0.20)之间，相比2024年亏损$(1.81)，正常化FFO为$1.56-$1.60，同比增长$1.56\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1048278264\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/5b82af1deb17dfa8f94b4741b9ea2738);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">财报速递 </p>\n<p class=\"h-time\">2025-02-19 20:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n公司预计2025年每股收益指南范围如下：2024年实际每股收益亏损$(1.81)，2025年预计为$(0.28)至$(0.20)；NAREIT每股FFO为$0.52，预计2025年在$1.44至$1.48之间；2024年正常化每股FFO为$1.56，预计2025年在$1.56至$1.60之间。公司的2025年同店现金NOI增长预计在3.00%到3.75%之间，不包括Prospect Medical和Steward Health的影响。<br><br>以上内容来自Benzinga Earnings专栏，原文如下：<br><html><body><p>GuidanceThe Company's 2025 per share estimated guidance ranges are as follows: ACTUAL 2025 GUIDANCE  2024  LOWHIGHEarnings per share$(1.81) <a href=\"https://laohu8.com/S/0.28\">$(0.28)$</a>(0.20)NAREIT FFO per</p><p>Guidance</p><ul><li>The Company's 2025 per share estimated guidance ranges are as follows:</li></ul><figure><table><tbody><tr><td> </td><td colspan=\"3\">ACTUAL</td><td> </td><td colspan=\"6\">2025 GUIDANCE</td></tr><tr><td> </td><td> </td><td>2024</td><td> </td><td colspan=\"4\"> LOW</td><td colspan=\"3\">HIGH</td></tr><tr><td>Earnings per share</td><td>$</td><td>(1.81</td><td>)</td><td> </td><td>$</td><td>(0.28</td><td>)</td><td>$</td><td>(0.20</td><td>)</td></tr><tr><td>NAREIT FFO per share</td><td>$</td><td>0.52</td><td> </td><td> </td><td>$</td><td>1.44</td><td> </td><td>$</td><td>1.48</td><td> </td></tr><tr><td>Normalized FFO per share</td><td>$</td><td>1.56</td><td> </td><td> </td><td>$</td><td>1.56</td><td> </td><td>$</td><td>1.60</td><td> </td></tr></tbody></table></figure><ul><li>The Company's 2025 same store cash NOI growth estimated guidance range is 3.00% to 3.75%, which excludes the impact of Prospect Medical and Steward Health.</li></ul></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"","article_id":"1143584451","we_media_id":"1048278264","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1143584451","pubTimestamp":1739966848,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"财报速递","introduction":"每日财报追踪","home_visible":1,"id":"1048278264","head_image":"https://community-static.tradeup.com/news/5b82af1deb17dfa8f94b4741b9ea2738"},"summary":"公司预计2025年每股收益指南范围如下：2024年实际每股收益亏损$，2025年预计为$至$；NAREIT每股FFO为$0.52，预计2025年在$1.44至$1.48之间；2024年正常化每股FFO为$1.56，预计2025年在$1.56至$1.60之间。公司的2025年同店现金NOI增长预计在3.00%到3.75%之间，不包括Prospect Medical和Steward Health的影响。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{},"translate_title":"Healthcare Realty expects an EPS loss of between $(0.28)-$(0.20) in 2025, compared to a loss of $(1.81) in 2024, and a normalized FFO of $1.56-$1.60, a year-on-year increase of $1.56","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HCSG":1,"HR":0.9},"content_text":"公司预计2025年每股收益指南范围如下：2024年实际每股收益亏损$(1.81)，2025年预计为$(0.28)至$(0.20)；NAREIT每股FFO为$0.52，预计2025年在$1.44至$1.48之间；2024年正常化每股FFO为$1.56，预计2025年在$1.56至$1.60之间。公司的2025年同店现金NOI增长预计在3.00%到3.75%之间，不包括Prospect Medical和Steward Health的影响。以上内容来自Benzinga Earnings专栏，原文如下：GuidanceThe Company's 2025 per share estimated guidance ranges are as follows: ACTUAL 2025 GUIDANCE  2024  LOWHIGHEarnings per share$(1.81) $(0.28)$(0.20)NAREIT FFO perGuidanceThe Company's 2025 per share estimated guidance ranges are as follows: ACTUAL 2025 GUIDANCE  2024  LOWHIGHEarnings per share$(1.81) $(0.28)$(0.20)NAREIT FFO per share$0.52  $1.44 $1.48 Normalized FFO per share$1.56  $1.56 $1.60 The Company's 2025 same store cash NOI growth estimated guidance range is 3.00% to 3.75%, which excludes the impact of Prospect Medical and Steward Health.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"express","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}